Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study 被引量：7

下载PDF

导出

摘要 Background:Vaccine effectiveness studies have not differentiated the effect of the delta(B.1.617.2)variant and potential waning immunity in observed reductions in effectiveness against SARS-CoV-2 infections.We aimed to evaluate overall and variant-specific effectiveness of BNT162b2(tozinameran,Pfizer-BioNTech)against SARS-CoV-2 infections and COVID-19-related hospital admissions by time since vaccination among members of a large US health-care system.

作者 Sara Y Tartof

机构地区不详

出处《四川生理科学杂志》 2021年第8期1408-1408,共1页 Sichuan Journal of Physiological Sciences

关键词 PFIZER IMMUNITY VACCINATION

分类号 R73 [医药卫生—肿瘤]

引文网络
相关文献

同被引文献21

1余文周,温宁,汪海波,张勇,许文波,樊春祥,罗会明,李黎.我国现阶段维持无脊髓灰质炎状态面临的挑战和对策[J].中国疫苗和免疫,2013,19(5):468-472. 被引量：40
2Yujia Jin,Cheng Lei,Dan Hu,Dimiter S. Dimitrov,Tianlei Ying.Human monoclonal antibodies as candidate therapeutics against emerging viruses[J].Frontiers of Medicine,2017,11(4):462-470. 被引量：8
3冯录召,彭质斌,王大燕,杨鹏,杨娟,张延炀,陈健,姜世强,徐莉立,康敏,陈涛,郑亚明,郑建东,秦颖,赵梦娇,谭亚运,李中杰,冯子健.中国流感疫苗预防接种技术指南（2018-2019）[J].中华预防医学杂志,2018,52(11):1101-1114. 被引量：57
4李海峰,张琴,胡月婷,熊杰,陈琴,徐祝英,吴一芩.某社区老年人接种23价肺炎球菌多糖疫苗的效果分析[J].中国医药指南,2019,17(32):25-26. 被引量：5
5谭敦民.“疫苗犹豫”成为世卫组织难题?[J].家庭医药（就医选药）,2020,0(2):8-9. 被引量：1
6张莉,杨鹏,段玮,王全意.2017-2018年流感流行季北京市中小学校流感疫苗接种对流感聚集性疫情的影响[J].国际病毒学杂志,2020,27(1):11-14. 被引量：19
7WU SHI-BO,ZHONG GONG-XUN,ZHANG JUN.表达SARS-CoV-2 S蛋白基因重组腺病毒疫苗对小鼠和雪貂的免疫保护力评价[J].中国预防兽医学报,2020,42(9):976-976. 被引量：32
8Andrew J.Gorzalski,Paul Hartley,Chris Laverdure,Heather Kerwin,Richard Tillett,Subhash Verma,Cyprian Rossetto,Sergey Morzunov,Stephanie Van Hooser,Mark W.Pandori.Characteristics of viral specimens collected from asymptomatic and fatal cases of COVID-19[J].The Journal of Biomedical Research,2020,34(6):431-436. 被引量：3
9Yunlong Cao,Ayijiang Yisimayi,Yali Bai,Weijin Huang,Xiaofeng Li,Zhiying Zhang,Tianjiao Yuan,Ran An,Jing Wang,Tianhe Xiao,Shuo Du,Wenping Ma,Liyang Song,Yongzheng Li,Xiang Li,Weiliang Song,Jiajing Wu,Shuo Liu,Xuemei Li,Yonghong Zhang,Bin Su,Xianghua Guo,Yangyang Wei,Chuanping Gao,Nana Zhang,Yifei Zhang,Yang Dou,Xiaoyu Xu,Rui Shi,Bai Lu,Ronghua Jin,Yingmin Ma,Chengfeng Qin,Youchun Wang,Yingmei Feng,Junyu Xiao,Xiaoliang Sunney Xie.Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines[J].Cell Research,2021,31(7):732-741. 被引量：21
10Hong Lei,Aqu Alu,Jingyun Yang,Cai He,Weiqi Hong,Zesheng Cheng,Li Yang,Jiong Li,Zhenling Wang,Wei Wang,Guangwen Lu,Xiawei Wei.Cationic nanocarriers as potent adjuvants for recombinant S-RBD vaccine of SARS-CoV-2[J].Signal Transduction and Targeted Therapy,2020,5(1):134-136. 被引量：1

引证文献7

1吕晓亚,宋磊,马昭,王曙光,马豪,邵一鸣,武治印.新型冠状病毒疫苗免疫策略的强化和优化[J].上海交通大学学报（医学版）,2021,41(12):1545-1550. 被引量：6
2Hong Lei,Aqu Alu,Jingyun Yang,Wenyan Ren,Cai He,Tianxia Lan,Xuemei He,Li Yang,Jiong Li,Zhenling Wang,Xiangrong Song,Wei Wang,Guangwen Lu,Xiawei Wei.Intranasal administration of a recombinant RBD vaccine induces long-term immunity against Omicron-included SARS-CoV-2 variants[J].Signal Transduction and Targeted Therapy,2022,7(6):2079-2091. 被引量：3
3刘晓辉,庄春兰,陈祺,黄守杰,吴婷.新型冠状病毒疫苗对病毒传播的阻断效果:现状与展望[J].中华微生物学和免疫学杂志,2022,42(10):753-760. 被引量：3
4李东升,吴忠兰,张愫,胡东生,崔长法.新型冠状病毒的演化和新冠病毒疫苗的免疫保护研究进展[J].药学进展,2022,46(10):736-744. 被引量：4
5武刚,王军志.治疗性新型冠状病毒抗体的研究进展[J].中国新药杂志,2022,31(21):2073-2081. 被引量：4
6李柔,凌飞翔,马礼兵.疫苗在呼吸道感染性疾病的应用及研究现状[J].实用医学杂志,2023,39(1):6-11. 被引量：4
7Zhaobin Xu,Jian Song,Weidong Liu,Dongqing Wei.An agent-based model with antibody dynamics information in COVID-19 epidemic simulation[J].Infectious Disease Modelling,2023,8(4):1151-1168.

二级引证文献24

1黄巍,吕鑫,朱建慧,郑亚明,陶懂谊,王敏.两种13价肺炎球菌多糖结合疫苗的接种安全性比较[J].海峡预防医学杂志,2023,29(5):106-108.
2Erri Du,Pengyu Jiang,Chaowei Zhang,Shan Zhang,Xiangyu Yan,Yongjie Li,Zhongwei Jia.COVID-19 Vaccination Rates of People Who Use Drugs—Chengdu City,Sichuan Province,China,November 2021–February 2022[J].China CDC weekly,2022,4(37):817-822.
3黄小红,刘书菡,肖湘珍,赵颖,胡崧,张天峰.“党建+集成管理”快速构建新冠肺炎免疫屏障的实践成效[J].现代医院,2022,22(10):1503-1506.
4何治尧,罗敏,杨莉,邓洪新,魏于全.肿瘤免疫与基因治疗研究进展[J].中国科学：生命科学,2022,52(11):1567-1577. 被引量：3
5余娜,刘玉娜,柏晓玲,张礼宪,龙梅,余汇.贵阳市≥60岁老年人新冠病毒疫苗加强免疫后AEFI主动监测分析[J].中国公共卫生,2022,38(9):1113-1117. 被引量：4
6孟伟,袁艺琳.迁移学习应用于新型冠状病毒肺炎诊断综述[J].计算机科学与探索,2023,17(3):561-576. 被引量：2
7阮连国,文丹宁,洪可,余婷,张丽,谢学磊,陈南山,黄正辉,黄朝林.金银花口服液治疗新型冠状病毒感染(湿热蕴肺证)有效性和安全性的随机、对照、开放式临床研究[J].中国医学创新,2023,20(6):27-32.
8王稳,马海军,郭明好.补体系统在COVID-19发病及进展中的研究进展[J].中华微生物学和免疫学杂志,2023,43(3):239-242.
9郭曼玉,缪宁,文艺,王富珍,崔健,刘怡,施露萌,尹遵栋,张国民.中国2022年疾病预防控制机构和预防接种单位疫苗冷链设备现况[J].中国疫苗和免疫,2023,29(2):144-147. 被引量：2
10许月,韩云玲,尹霞.应用课题研究型品管圈构建CDC-医院-社区三方联动的新冠病毒疫苗接种管理模式[J].智慧健康,2023,9(9):287-290. 被引量：1

1无,ZHAO Hui.Analysis of the Paper Entitled Traditional Chinese Medicine Use in the Treatment of Acute Heart Failure in Western Medicine Hospitals in China[J].Chinese Journal of Integrative Medicine,2020,26(3):165-167. 被引量：2
2Yair Goldberg.Waning Immunity after the BNT162b2 Vaccine in Israel[J].四川生理科学杂志,2021,43(8):1378-1378.
3Hon Foong Wong,Shih Chau Ng,Wen Tien Tan,Huiying Wang,Xun Lin,Si Woei Goh,Bao Ling Hoo,Chyong En Chai,Jun Liu.Traditional Chinese Medicine in Malaysia: A Brief Historical Overview of Laws and Regulations[J].Chinese Medicine and Culture,2019,2(4):162-165.
4Hazem Mohamed,Kar Teoh.Outcome of selective CT vs. pan-CT scan in elderly trauma patients: A retrospective cohort study in a level 1 trauma center[J].Chinese Journal of Traumatology,2021,24(5):249-254.
5Lei Yang,Yanhui Cheng,Xiang Zhao,Hejiang Wei,Minju Tan,Xiyan Li,Wenfei Zhu,Weijuan Huang,Wenbing Chen,Jia Liu,Zi Li,Yuelong Shu,Dayan Wang.Mutations associated with egg adaptation of influenza A(H1N1)pdm09 virus in laboratory based surveillance in China, 2009–2016[J].Biosafety and Health,2019,1(1):41-45. 被引量：1
6Dror Mevorach.Myocarditis after BNT162b2 mRNA Vaccine against Covid-19 in Israel[J].四川生理科学杂志,2021,43(8):1435-1435. 被引量：1
7Kook Hyun Kim,Sung Bum Kim.Comparison of the impact of endoscopic retrograde cholangiopancreatography between pre-COVID-19 and current COVID-19 outbreaks in South Korea:Retrospective survey[J].World Journal of Clinical Cases,2021,9(28):8404-8412.
8Xian-Yan Tang,Man Cheng,Alan Geater,Qiu-Yun Deng,Ge Zhong,Yue-Dong Lin,Ning Chen,Tao Lan,Long-Yan Jiang,Man-Tong Zhu,Qiao Li.Multi-level determinants of failure to receive timely and complete measles vaccinations in Southwest China:a mixed methods study[J].Infectious Diseases of Poverty,2021,10(4):100-101.
9Solmaz Sohrabei,Alireza Atashi.Application of Virtual Reality in Rehabilitation of Disabilities:A Mini Review[J].Journal of Pharmacy and Pharmacology,2021,9(5):214-221.
10Richard Brightwell,Ray Bange.Pre hospital medical services and paramedic engagement in Australian health care - Improving the pathways of care through collaborative action[J].Family Medicine and Community Health,2014,2(4):1-12. 被引量：4

四川生理科学杂志

2021年第8期

浏览历史

内容加载中请稍等...

Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study 被引量：7

同被引文献21

引证文献7

二级引证文献24

相关作者

相关机构

相关主题

浏览历史